Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “EPCAM”

42 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 42 results

Early research (Phase 1)Study completedNCT06386653
What this trial is testing

Molecular Imaging of EpCAM Receptors Using [123I]I-DARPIN-Ec1

Who this might be right for
Lung CancerOvarian Cancer
Tomsk National Research Medical Center of the Russian Academy of Sciences 10
Not applicableLooking for participantsNCT07472686
What this trial is testing

Small Bowel Capsule Endoscopy in Lynch Syndrome

Who this might be right for
MMR MutationSmall Bowel AdenomaSmall-bowel Adenocarcinoma+2 more
Assistance Publique - Hôpitaux de Paris 400
Large-scale testing (Phase 3)Study completedNCT00836654
What this trial is testing

Study in EpCAM Positive Patients With Symptomatic Malignant Ascites Using Removab Versus an Untreated Control Group

Who this might be right for
EpCam Positive Tumor (e.g.Ovarian, Gastric, Colon, Breast)Malignant Ascites
Neovii Biotech 258
Not applicableStudy completedNCT04290923
What this trial is testing

Determination of Blood Tumor Cells

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-CellAbnormalities Cell Epithelial
University of Zurich 71
Not applicableActive Not RecruitingNCT04009148
What this trial is testing

Cascade Testing in Families With Newly Diagnosed Hereditary Breast and Ovarian Cancer Syndrome

Who this might be right for
BRCA-Mutated Ovarian CarcinomaBRIP1 Gene MutationMSH2 A636P+5 more
NYU Langone Health 118
Early research (Phase 1)Ended earlyNCT00481936
What this trial is testing

Study of the Safety of VB6-845 in Patients With Advanced Solid Tumours of Epithelial Origin

Who this might be right for
Neoplasms, Glandular and Epithelial
Sesen Bio, Inc. 15
Testing effectiveness (Phase 2)UnknownNCT03146637
What this trial is testing

Study of Activated CIK Armed With Bispecific Antibody for Advanced Liver Cancer

Who this might be right for
Advanced Liver Cancer
Benhealth Biopharmaceutical (Shenzhen) Co., Ltd. 80
Testing effectiveness (Phase 2)Study completedNCT01504256
What this trial is testing

Catumaxomab for Treatment of Peritoneal Carcinomatosis in Patients With Gastric Adenocarcinomas

Who this might be right for
Gastric Adenocarcinoma With Peritoneal CarcinomatosisSiewert Type II Adenocarcinoma of Esophagogastric Junction With Peritoneal CarcinomatosisSiewert Type III Adenocarcinoma of Esophagogastric Junction With Peritoneal Carcinomatosis
AIO-Studien-gGmbH 42
Early research (Phase 1)Looking for participantsNCT05687682
What this trial is testing

Safety of AM-928 Infusion in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
AcadeMab Biomedical Inc. 38
Testing effectiveness (Phase 2)Study completedNCT00563836
What this trial is testing

Phase II Study of the Trifunctional Antibody Catumaxomab Administered Intra- and Postoperatively in Patients With Ovarian Cancer

Who this might be right for
Ovarian CancerEpithelial Ovarian Cancer
Neovii Biotech 41
Early research (Phase 1)UnknownNCT04819399
What this trial is testing

Investigation of Safety and Tolerability of Catumaxomab in Patients With NMIBC

Who this might be right for
Urinary Bladder Neoplasms
Lindis Biotech GmbH 30
Early research (Phase 1)Study completedNCT04501744
What this trial is testing

M701 (EpCAM and CD3) in Malignant Ascites

Who this might be right for
Malignant AscitesCancer
Wuhan YZY Biopharma Co., Ltd. 35
Testing effectiveness (Phase 2)Study completedNCT00352833
What this trial is testing

Safety and Efficacy Study With Catumaxomab in Patients After Curative Resection of a Gastric Adenocarcinoma

Who this might be right for
Gastric CancerGastric Adenocarcinoma
Neovii Biotech 40
Testing effectiveness (Phase 2)Study completedNCT00326885
What this trial is testing

Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites

Who this might be right for
Malignant Ascites
Neovii Biotech 32
Testing effectiveness (Phase 2)Study completedNCT00464893
What this trial is testing

Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative Resection

Who this might be right for
Gastric CancerGastric Adenocarcinoma
Neovii Biotech 70
Not applicableLooking for participantsNCT07400263
What this trial is testing

Evaluation of an EpCAM-Targeted Radiotracer in Epithelial Tumors

Who this might be right for
Epithelial Tumors, Malignant
Peking University People's Hospital 30
Not applicableStudy completedNCT06789224
What this trial is testing

Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device

Who this might be right for
Bladder CarcinomaProstate TumorGallbladder Carcinoma+9 more
Lindis Bloodcare GmbH 136
Not applicableUnknownNCT05576519
What this trial is testing

Immunohistochemical Expression of Epithelial Cell Adhesion Molecule (EpCAM) in Epithelial Ovarian Carcinoma

Who this might be right for
Ovarian Carcinoma
Sohag University 50
Early research (Phase 1)Study completedNCT00132522
What this trial is testing

EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide

Who this might be right for
Ovarian CancerColorectal CancerCarcinoma, Non-small-cell Lung+1 more
EMD Serono 45
Not applicableUnknownNCT04151186
What this trial is testing

A Clinical Study on the Safety and Efficacy of CAR-T Therapy for the TM4SF1- and EpCAM-positive Solid Tumors

Who this might be right for
Advanced Solid TumorNeoplasms
suhaichuan 72
Load More Results